Overview

Adult Subjects With Uncontrolled Type 2 Diabetes

Status:
Completed

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

A Multi-center, Double Blind, Randomized, Placebo-controlled, Parallel Group Phase IIa Study of MLR-1023 in Adult Subjects With Uncontrolled Type 2 Diabetes

Phase:

Phase 2

Details

Lead Sponsor:

Melior Pharmaceuticals

Collaborator:

Bukwang Pharmaceutical, Co., Ltd.